| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/04/2004 | WO2004018633A2 Abca13 nucleic acids and proteins, and uses thereof |
| 03/04/2004 | WO2004018631A2 G-protein coupled receptors |
| 03/04/2004 | WO2004018630A2 Recombinant double-stranded rna phages and uses thereof |
| 03/04/2004 | WO2004018629A2 Stars-a muscle-specification-binding protein |
| 03/04/2004 | WO2004018628A2 Charged peptide-amphiphile solutions & self-assembled peptide nanofiber networks formed therefrom |
| 03/04/2004 | WO2004018627A2 Methods for propagating adenovirus and virus produced thereby |
| 03/04/2004 | WO2004018625A2 Ovarian cancer-specific promoter |
| 03/04/2004 | WO2004018624A2 Random transposon insertion in staphylococcus aureus and use thereof to identify essential genes |
| 03/04/2004 | WO2004018619A2 P53 binding t cell receptor molecules and uses thereof |
| 03/04/2004 | WO2004018615A1 Fibrin-containing composition |
| 03/04/2004 | WO2004018520A1 Chimeric mhc protein and oligomer thereof |
| 03/04/2004 | WO2004018518A1 Human solid cancer antigen peptides, polynucleotides encoding the same and utilization thereof |
| 03/04/2004 | WO2004018517A2 POLYPEPTIDE HAVING GnSAF ACTIVITY AND SYNTHETIC ANTIBODIES |
| 03/04/2004 | WO2004018516A1 Regulation of human secretin-type gpcr (latrophilin) |
| 03/04/2004 | WO2004018515A2 T-cell epitopes in erythropoietin |
| 03/04/2004 | WO2004018514A1 Polypeptides of nontypeable haemophilus influenzae and corresponding dna fragments |
| 03/04/2004 | WO2004018513A1 Use of lectin library for distinguishing glycoproteins or cells, diagnosing serum or cells, or fractionating glycoproteins or cells |
| 03/04/2004 | WO2004018512A2 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications |
| 03/04/2004 | WO2004018511A2 Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins |
| 03/04/2004 | WO2004018509A1 Improved mutants of biotin binding protein |
| 03/04/2004 | WO2004018508A1 A protein controlling rice tiller, a gene encoding the protein and a method of manipulating plant tiller or branching using the gene |
| 03/04/2004 | WO2004018507A1 Compositions and methods for treatment and prophylaxis of infections caused by gram positive bacteria |
| 03/04/2004 | WO2004018505A1 Akap84 and its use for visualization of biological structures |
| 03/04/2004 | WO2004018502A1 Compounds binding to p-selectin |
| 03/04/2004 | WO2004018499A2 Synthetic heparin-binding growth factor analogs |
| 03/04/2004 | WO2004018498A2 Minicell display and products therefrom |
| 03/04/2004 | WO2004017991A1 Use of iap for the diagnosis and of iap-inhibitors for the treatment of hodgkin’s lymphomas |
| 03/04/2004 | WO2004017990A1 Vaccine for respiratory and reproductive system infections in cattle |
| 03/04/2004 | WO2004017987A2 Heterocarpin, a plant-derived protein with anti-cancer properties |
| 03/04/2004 | WO2004017985A1 Multifunctional context-activated protides and methods of use |
| 03/04/2004 | WO2004017926A2 Use of novel cytokine receptors as biomarkers and therapeutic targets in human cancer |
| 03/04/2004 | WO2004017727A1 A method of treatment and prophylaxis |
| 03/04/2004 | WO2004007538A3 Molecular antigen arrays using a virus like particle derived from the ap205 coat protein |
| 03/04/2004 | WO2004004455A3 Composition and method for stabilising biomolecules |
| 03/04/2004 | WO2004003563A3 Diagnostic and therapeutic use of ensadin-0581 gene and protein for neurodegenerative diseases |
| 03/04/2004 | WO2004001020A3 Methods and means to promote gut absorption |
| 03/04/2004 | WO2003106674A3 Use of repression blocking sequences in methods for enhancing gene expression |
| 03/04/2004 | WO2003103720A3 Compositions and methods for the use of bcl-2 transfected neurons |
| 03/04/2004 | WO2003103577A3 Novel recombinant anticoagulant proteins |
| 03/04/2004 | WO2003101173A3 Immunomodulatory constructs and their uses |
| 03/04/2004 | WO2003097871A8 Marker molecules associated with lung tumors |
| 03/04/2004 | WO2003097678A3 Use of the repressor glxr for the synthesis of lysine in corynebacterium glutamicum |
| 03/04/2004 | WO2003097091A3 Glucan-based vaccines |
| 03/04/2004 | WO2003097086A3 Egf receptor antagonists in the treatment of gastric cancer |
| 03/04/2004 | WO2003095653B1 Promoters having a modified transcription efficiency and derived from methyltrophic yeast |
| 03/04/2004 | WO2003093468A3 Expression system for large functional proteins |
| 03/04/2004 | WO2003080657A3 Yeast pheromones for the treatment of infectious diseases |
| 03/04/2004 | WO2003074555A3 Synthetic peptides from c. difficile |
| 03/04/2004 | WO2003073107A3 Neuropeptide receptor and uses thereof |
| 03/04/2004 | WO2003072787A3 Method for detection of leptin receptor ligands |
| 03/04/2004 | WO2003070941A3 Method for the identification of tissue-specific regulatory sequences |
| 03/04/2004 | WO2003070760A3 Anti-amyloid beta antibodies and their use |
| 03/04/2004 | WO2003068912A3 PSEUDOMONAS SYRINGAE HARPINS, HopPtoP AND HopPmaHPTO, AND THEIR USES |
| 03/04/2004 | WO2003068822A3 De-immunized (poly)peptide constructs |
| 03/04/2004 | WO2003062830A3 Fibronectin variants and screening methods |
| 03/04/2004 | WO2003062455A3 Zinc finger domain recognition code and uses thereof |
| 03/04/2004 | WO2003062446A9 Mrp9 and its use detecting and treating cancer |
| 03/04/2004 | WO2003057720A3 Recovery of biofilament proteins from biological fluids |
| 03/04/2004 | WO2003057174A3 Methods and compositions for protein expression and purification |
| 03/04/2004 | WO2003056294A3 Methods for identifying and using marr family polypeptide binding compounds |
| 03/04/2004 | WO2003055980A3 Il-17 like molecules and uses thereof |
| 03/04/2004 | WO2003055905A3 Proteins of non typable haemophilus influenzae |
| 03/04/2004 | WO2003054006A3 Mutated hiv tat |
| 03/04/2004 | WO2003052122A3 Gp41 inhibitor |
| 03/04/2004 | WO2003052094A3 Expression vector for the production of annexin v |
| 03/04/2004 | WO2003051914A3 Ides, an igg-degrading enzyme of streptococcus pyogenes |
| 03/04/2004 | WO2003051912A3 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 03/04/2004 | WO2003050311A3 Methods and compositions for diagnosing and treating hypotrichosis simplex |
| 03/04/2004 | WO2003050300A3 Diagnosis and treatment of cancer |
| 03/04/2004 | WO2003050254A3 Novel chimeric tnf ligands |
| 03/04/2004 | WO2003045988A3 Method to isolate genes involved in aging |
| 03/04/2004 | WO2003044054A3 Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases |
| 03/04/2004 | WO2003040290A3 Genes from corynebacterium glutamicum that code for homeostasis proteins and for adaptation proteins |
| 03/04/2004 | WO2003039225A3 Antigen arrays comprising rankl for treatment of bone disease |
| 03/04/2004 | WO2003037928A3 Analogs of human growth hormone-releasing hormone, their preparation and use |
| 03/04/2004 | WO2003037267A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 03/04/2004 | WO2003037251A3 Hivgp120-induced bob/gpr15 activation |
| 03/04/2004 | WO2003035683A3 Surfactant protein-d and atherosclerosis |
| 03/04/2004 | WO2003029399A3 Regulatory sequence for the specific expression in fruit of a gene and the applications thereof |
| 03/04/2004 | WO2003025176A8 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 03/04/2004 | WO2003025007A3 Purified polypeptides involved in membrane biosynthesis |
| 03/04/2004 | WO2003025004A3 Purified bacterial polypeptides involved in nucleic acid processing |
| 03/04/2004 | WO2003017751A3 Combinations of genes for producing seed plants exhibiting modulated reproductive development |
| 03/04/2004 | WO2003016536A3 Plasmids from anaerocellum thermophilum and uses thereof |
| 03/04/2004 | WO2003016348A3 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine |
| 03/04/2004 | WO2003008571A3 Chimeric chains that code for proteins that induce effects directed against viruses |
| 03/04/2004 | WO2003002136A3 Stable formulation of modified glp-1 |
| 03/04/2004 | WO2003000846A3 A novel g protein-coupled receptor, gave 3 |
| 03/04/2004 | WO2002102848A3 Nucleic acid and amino acid sequences of a vegf variant |
| 03/04/2004 | WO2002095049A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 03/04/2004 | WO2002092818A8 Streptococcus agalactiae genome sequence, use for developing vaccines, diagnostic tools, and for identifying therapeutic targets |
| 03/04/2004 | WO2002092762A3 Cytokine polypeptides |
| 03/04/2004 | WO2002082091A3 Method for identification of proteins from intracellular bacteria |
| 03/04/2004 | WO2002078640A3 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
| 03/04/2004 | WO2002072764A8 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/04/2004 | WO2002072606A3 Epitope testing using hla |
| 03/04/2004 | WO2002059621A3 Regulation of transthyretin to treat obesity |
| 03/04/2004 | WO2002048310A9 Methods and compositions for diagnosing and treating rheumatoid arthritis |
| 03/04/2004 | WO2002044424A9 Compositions, methods, apparatus and products comprising a stathmin/oncoprotein 18 sequence for detecting and treating cancer |
| 03/04/2004 | WO2002026931A3 71 human secreted proteins |